BioNTech (BNTX)
(Delayed Data from NSDQ)
$99.26 USD
+1.38 (1.41%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $99.24 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BNTX 99.26 +1.38(1.41%)
Will BNTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BNTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNTX
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?
BNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold?
SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study
BMY Stock Trades Near 52-Week Low: Time to Buy or Sell?
Other News for BNTX
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Pfizer, Moderna post data supporting COVID shots after Trump demand
Is BNTX poised for a decline? Jack-in-the-box Bearish shows up after rising 1.18%
Five new members added to CDC vaccine advisory panel
Former Trump surgeon general says RFK Jr. must go